We are live on ! Find out more
ACM

AlphaCrest Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$532M
Cap. Flow
+$466M
Cap. Flow %
20.05%
Top 10 Hldgs %
5.87%
Holding
1,402
New
244
Increased
583
Reduced
375
Closed
199

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$17.3M
2
NKE icon
Nike
NKE
+$16.2M
3
MRK icon
Merck
MRK
+$13.4M
4
CMCSA icon
Comcast
CMCSA
+$12.8M
5
MSFT icon
Microsoft
MSFT
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 19.18%
2 Financials 14.64%
3 Healthcare 14.37%
4 Industrials 13.29%
5 Consumer Discretionary 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
1051
DELISTED
Coterra Energy
CTRA
$372K 0.02%
+21,297
New +$362K
AGNT
1052
AGNT Inc
AGNT
$666M
$372K 0.02%
+9,600
New +$331K
NSIT icon
1053
Insight Enterprises
NSIT
$3.89B
$372K 0.02%
+3,716
New +$376K
DDOG icon
1054
Datadog
DDOG
$95.4B
$371K 0.02%
3,568
-5,532
-61% -$500K
IRDM icon
1055
Iridium Communications
IRDM
$5.02B
$371K 0.02%
+9,287
New +$361K
TRU icon
1056
TransUnion
TRU
$15.1B
$367K 0.02%
3,341
-12,875
-79% -$1.34M
HCSG icon
1057
Healthcare Services Group
HCSG
$1.6B
$366K 0.02%
11,585
-7,287
-39% -$222K
STAA icon
1058
STAAR Surgical
STAA
$1.21B
$366K 0.02%
+2,400
New +$316K
MSTR icon
1059
Strategy Inc
MSTR
$34.1B
$365K 0.02%
5,490
-3,510
-39% -$208K
ATR icon
1060
AptarGroup
ATR
$8.55B
$363K 0.02%
2,577
+959
+59% +$141K
AUDC icon
1061
AudioCodes
AUDC
$244M
$361K 0.02%
10,918
-1,107
-9% -$35.4K
FOLD
1062
DELISTED
Amicus Therapeutics
FOLD
$360K 0.02%
37,361
-32,678
-47% -$319K
RMBS icon
1063
Rambus
RMBS
$9.87B
$358K 0.02%
15,088
-87,791
-85% -$1.77M
CHH icon
1064
Choice Hotels
CHH
$5.07B
$355K 0.02%
+2,989
New +$348K
AAT
1065
American Assets Trust
AAT
$1.45B
$354K 0.02%
+9,503
New +$338K
SHAK icon
1066
Shake Shack
SHAK
$2.53B
$351K 0.02%
3,278
+1,235
+60% +$125K
AVNT icon
1067
Avient
AVNT
$3.33B
$349K 0.02%
7,091
-4,674
-40% -$236K
MRCY icon
1068
Mercury Systems
MRCY
$5.83B
$349K 0.02%
+5,272
New +$364K
TECK icon
1069
Teck Resources
TECK
$29.6B
$348K 0.02%
+15,100
New +$343K
EYE icon
1070
National Vision
EYE
$1.77B
$347K 0.01%
6,782
-3,318
-33% -$163K
MMSI icon
1071
Merit Medical Systems
MMSI
$5.08B
$347K 0.01%
5,368
-1,473
-22% -$91.1K
VICI icon
1072
VICI Properties
VICI
$29B
$347K 0.01%
11,176
-21,673
-66% -$672K
IRTC icon
1073
iRhythm Holdings
IRTC
$3.85B
$344K 0.01%
5,189
+2,376
+84% +$188K
SGRY icon
1074
Surgery Partners
SGRY
$2.01B
$344K 0.01%
+5,164
New +$280K
DOW icon
1075
Dow Inc
DOW
$21.9B
$342K 0.01%
5,400
-1,400
-21% -$92.4K

Similar funds

AlphaCrest Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, AlphaCrest Capital Management held 1,402 positions worth $2.33B, up 30% from $1.79B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

AlphaCrest Capital Management deployed $466M of net new capital in Q2 2021, opening 244 new positions and adding to 583 existing holdings. Its largest new stake was Nucor: 85,982 shares worth $8.25M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Morgan Stanley, an estimated $17.3M trimmed.

  • AlphaCrest Capital Management's largest Q2 2021 buy was Nucor: 85,982 shares worth $8.25M.
  • AlphaCrest Capital Management added most to Fiserv Inc in Q2 2021, an estimated $12.3M increase.
  • AlphaCrest Capital Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $17.3M.
  • AlphaCrest Capital Management fully exited Merck in Q2 2021, selling an estimated $13.4M.
  • AlphaCrest Capital Management's ten largest holdings make up 5.9% of its $2.33B portfolio in Q2 2021.
  • AlphaCrest Capital Management opened 244 new positions and closed 199 in Q2 2021.
  • AlphaCrest Capital Management's portfolio value rose 30% quarter-over-quarter to $2.33B.

Based on AlphaCrest Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.